selegiline has been researched along with Glioma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baskin, AM; Baskin, DS; Han, J; Sharpe, MA | 1 |
| Suzuki, O | 1 |
| Boulton, AA; Juorio, AV; Li, XM; Qi, J | 1 |
| Yu, PH; Zuo, D | 1 |
| Kondakova, LI; Medvedev, AE; Moskvitina, TA; Navasardyantz, DG; Podobed, OV; Tsvetkova, TA; Yakusheva, IV | 1 |
| Mertz, K; Morgan, JI; Schmidt, J | 1 |
1 review(s) available for selegiline and Glioma
| Article | Year |
|---|---|
[Current status of type A and type B monoamine oxidase (author's transl)].
Topics: Animals; Brain Chemistry; Brain Neoplasms; Cattle; Clorgyline; Glioma; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline; Substrate Specificity | 1980 |
5 other study(ies) available for selegiline and Glioma
| Article | Year |
|---|---|
Design and synthesis of a MAO-B-selectively activated prodrug based on MPTP: a mitochondria-targeting chemotherapeutic agent for treatment of human malignant gliomas.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Antineoplastic Agents; Drug Delivery Systems; Drug Design; Glioma; Humans; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Prodrugs; Selegiline | 2015 |
Reduction in glial fibrillary acidic protein mRNA abundance induced by (-)-deprenyl and other monoamine oxidase B inhibitors in C6 glioma cells.
Topics: Animals; Brain Neoplasms; Dose-Response Relationship, Drug; Gene Expression; Glial Fibrillary Acidic Protein; Glioma; Monoamine Oxidase; Monoamine Oxidase Inhibitors; RNA, Messenger; Selegiline; Stereoisomerism; Time Factors; Tumor Cells, Cultured | 1993 |
Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)-deprenyl.
Topics: Brain Neoplasms; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Glioma; Humans; Neuroblastoma; Oxidopamine; Selegiline; Tumor Cells, Cultured | 1995 |
Modulation of glutamate neurotoxicity in the transformed cell culture by monoamine oxidase inhibitors, clorgyline and deprenyl.
Topics: Animals; Cell Division; Cell Line, Transformed; Cell Survival; Clorgyline; DNA, Neoplasm; Glioma; Glutamic Acid; Kinetics; L-Lactate Dehydrogenase; Monoamine Oxidase Inhibitors; Neurotoxins; Rats; Selegiline; Time Factors; Tumor Cells, Cultured | 1998 |
Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Astrocytes; Catechol O-Methyltransferase Inhibitors; Catechols; Cell Line; Cycloheximide; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glioma; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hemin; Membrane Proteins; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; RNA, Messenger; Selegiline; Time Factors; Tumor Cells, Cultured | 1999 |